The current analyst and expert consensus on Dimension Therapeutics is Buy with 0 strong sell and 2 strong buy opinions. The current projected target price consensus is 16.33 with 3 analysts opinions. The most common way Dimension Therapeutics analysists use to provide recommendation to public is financial statements analysis. Many experts also interview Dimension Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on Dimension Therapeutics. We encourage you to use your own analysis of Dimension Therapeutics to validate this buy or sell advice. Dimension Therapeutics buy or sell recommendation module provides average expert sentiment on the projected Dimension Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 13.65. Additionally see Macroaxis Advice on Dimension Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.